Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • PZWL
  • Reduced price
Targeting Oncogenic Driver Mutations in Lung Cancer

Targeting Oncogenic Driver Mutations in Lung Cancer

9781009336130
107.10 zł
96.39 zł Save 10.71 zł Tax included
Lowest price within 30 days before promotion: 96.39 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This Element highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management.
Product Details
Cambridge University Press
97928
9781009336130
9781009336130

Data sheet

Publication date
2023
Issue number
1
Cover
paperback
Pages count
75
Dimensions (mm)
152.00 x 227.00
Weight (g)
160
  • 1. Introduction; 2. ALK gene rearrangements; 3. ROSI gene rearrangements; 4. RET gene rearrangements; 5. MET alterations; 6. KRAS point mutations; 7. B-RAF point mutations; 8. NTRK1/2/3 gene fusions; 9. ERBB2 (HER2) mutations; 10. Diagnostic strategies; References.
Comments (0)

  • Frequently purchased together

    No products available